1. Home
  2. PIII vs ABVC Comparison

PIII vs ABVC Comparison

Compare PIII & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo P3 Health Partners Inc.

PIII

P3 Health Partners Inc.

N/A

Current Price

$7.88

Market Cap

33.8M

Sector

Health Care

ML Signal

N/A

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

N/A

Current Price

$1.15

Market Cap

34.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PIII
ABVC
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
34.6M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
PIII
ABVC
Price
$7.88
$1.15
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
18.2K
100.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.14
EPS
N/A
N/A
Revenue
$1,459,080,000.00
$509,589.00
Revenue This Year
$7.67
N/A
Revenue Next Year
$2.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.52
$0.71
52 Week High
$16.89
$3.39

Technical Indicators

Market Signals
Indicator
PIII
ABVC
Relative Strength Index (RSI) 31.75 55.71
Support Level $2.39 $0.96
Resistance Level $11.55 $1.14
Average True Range (ATR) 0.45 0.08
MACD -0.12 0.03
Stochastic Oscillator 4.66 89.04

Price Performance

Historical Comparison
PIII
ABVC

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Share on Social Networks: